Sure, things can always get better. I believe
Post# of 30027
(Total Views: 378)
Posted On: 01/08/2022 9:59:38 AM
.jpg)
Sure, things can always get better.
I believe on positive phase 2 data Todos will open at $0.12 and close at $.18. A few weeks later, after some other news, I think we will get a massive Q4 10Q with a conference call that answers Q1 revenue projections and we have built up to a close at $.35, which is a pretty reasonable market cap at $350M. From there, I think we will set the R/S at 1:25 and uplist around $9 with a final O/S of 45M and A/S of 200M shares after the capital raise end of March that will fall alongside a 10-k. That will mean we have $50-60M of cash in the bank to run a full phase 3 and rapidly progress Videssa in 2022.
At that point AMBS stake can securely be liquidated for around $30M which solves ALLLLLLL our worries and then some!
I believe on positive phase 2 data Todos will open at $0.12 and close at $.18. A few weeks later, after some other news, I think we will get a massive Q4 10Q with a conference call that answers Q1 revenue projections and we have built up to a close at $.35, which is a pretty reasonable market cap at $350M. From there, I think we will set the R/S at 1:25 and uplist around $9 with a final O/S of 45M and A/S of 200M shares after the capital raise end of March that will fall alongside a 10-k. That will mean we have $50-60M of cash in the bank to run a full phase 3 and rapidly progress Videssa in 2022.
At that point AMBS stake can securely be liquidated for around $30M which solves ALLLLLLL our worries and then some!
(4)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼